25 XP   0   0   10

Coloplast A/S
Buy, Hold or Sell?

Let's analyse Coloplast together

PenkeI guess you are interested in Coloplast A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Coloplast A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Coloplast A/S

I send you an email if I find something interesting about Coloplast A/S.

Quick analysis of Coloplast (30 sec.)










What can you expect buying and holding a share of Coloplast? (30 sec.)

How much money do you get?

How much money do you get?
kr3.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
kr67.27
Expected worth in 1 year
kr106.75
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
kr60.46
Return On Investment
6.6%

For what price can you sell your share?

Current Price per Share
kr915.20
Expected price per share
kr837.18 - kr977.60
How sure are you?
50%

1. Valuation of Coloplast (5 min.)




Live pricePrice per Share (EOD)

kr915.20

Intrinsic Value Per Share

kr177.79 - kr539.40

Total Value Per Share

kr245.07 - kr606.67

2. Growth of Coloplast (5 min.)




Is Coloplast growing?

Current yearPrevious yearGrowGrow %
How rich?$2.1b$1b$614.1m37.4%

How much money is Coloplast making?

Current yearPrevious yearGrowGrow %
Making money$173.7m$165.1m$8.6m5.0%
Net Profit Margin19.5%19.7%--

How much money comes from the company's main activities?

3. Financial Health of Coloplast (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#28 / 171

Most Revenue
#29 / 171

Most Profit
#17 / 171

What can you expect buying and holding a share of Coloplast? (5 min.)

Welcome investor! Coloplast's management wants to use your money to grow the business. In return you get a share of Coloplast.

What can you expect buying and holding a share of Coloplast?

First you should know what it really means to hold a share of Coloplast. And how you can make/lose money.

Speculation

The Price per Share of Coloplast is kr915.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Coloplast.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Coloplast, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr67.27. Based on the TTM, the Book Value Change Per Share is kr9.87 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr5.25 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Coloplast.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.770.1%0.800.1%0.780.1%0.750.1%0.620.1%
Usd Book Value Change Per Share-1.39-0.2%1.410.2%-0.080.0%0.310.0%0.140.0%
Usd Dividend Per Share2.280.2%0.750.1%1.430.2%1.080.1%0.920.1%
Usd Total Gains Per Share0.890.1%2.160.2%1.340.1%1.390.2%1.060.1%
Usd Price Per Share110.24-116.90-122.12-127.85-101.15-
Price to Earnings Ratio35.80-36.77-40.21-42.91-5.53-
Price-to-Total Gains Ratio123.24-166.60-131.41-151.64-117.29-
Price to Book Ratio11.48-19.09-25.69-27.18-24.25-
Price-to-Total Gains Ratio123.24-166.60-131.41-151.64-117.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share130.69056
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.751.08
Usd Book Value Change Per Share1.410.31
Usd Total Gains Per Share2.161.39
Gains per Quarter (7 shares)15.119.73
Gains per Year (7 shares)60.4338.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
121395030929
24279110611768
3631181709126107
48415823012134146
510519729015243185
612623735018251224
714727641021260263
816831647024369302
918935553027377341
1021039559030386380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%59.02.00.096.7%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%11.09.00.055.0%19.021.00.047.5%33.025.03.054.1%
Dividend per Share2.00.02.050.0%10.00.02.083.3%16.00.04.080.0%30.00.010.075.0%37.00.024.060.7%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%57.02.02.093.4%

Fundamentals of Coloplast

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Fundamental data was last updated by Penke on 2024-03-30 09:20:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Coloplast A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Coloplast earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 18.3% means that kr0.18 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Coloplast A/S:

  • The MRQ is 18.3%. The company is making a huge profit. +2
  • The TTM is 19.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.3%TTM19.5%-1.1%
TTM19.5%YOY19.7%-0.2%
TTM19.5%5Y21.7%-2.2%
5Y21.7%10Y20.3%+1.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ18.3%6.3%+12.0%
TTM19.5%6.5%+13.0%
YOY19.7%8.2%+11.5%
5Y21.7%7.3%+14.4%
10Y20.3%7.3%+13.0%
1.1.2. Return on Assets

Shows how efficient Coloplast is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 2.5% Return on Assets means that Coloplast generated kr0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Coloplast A/S:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.5%TTM3.0%-0.5%
TTM3.0%YOY3.3%-0.3%
TTM3.0%5Y5.9%-2.9%
5Y5.9%10Y6.1%-0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%1.3%+1.2%
TTM3.0%1.4%+1.6%
YOY3.3%2.0%+1.3%
5Y5.9%2.2%+3.7%
10Y6.1%2.0%+4.1%
1.1.3. Return on Equity

Shows how efficient Coloplast is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 8.0% Return on Equity means Coloplast generated kr0.08 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Coloplast A/S:

  • The MRQ is 8.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.0%TTM12.8%-4.8%
TTM12.8%YOY16.3%-3.5%
TTM12.8%5Y15.9%-3.1%
5Y15.9%10Y14.7%+1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0%2.6%+5.4%
TTM12.8%2.9%+9.9%
YOY16.3%3.9%+12.4%
5Y15.9%3.9%+12.0%
10Y14.7%4.0%+10.7%

1.2. Operating Efficiency of Coloplast A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Coloplast is operating .

  • Measures how much profit Coloplast makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Coloplast A/S:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM13.9%-13.9%
TTM13.9%YOY27.9%-14.1%
TTM13.9%5Y27.4%-13.6%
5Y27.4%10Y29.9%-2.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%-8.0%
TTM13.9%7.3%+6.6%
YOY27.9%11.4%+16.5%
5Y27.4%10.1%+17.3%
10Y29.9%10.7%+19.2%
1.2.2. Operating Ratio

Measures how efficient Coloplast is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are kr1.04 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Coloplast A/S:

  • The MRQ is 1.042. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.888. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.042TTM0.888+0.154
TTM0.888YOY0.701+0.187
TTM0.8885Y0.726+0.162
5Y0.72610Y0.702+0.025
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0421.129-0.087
TTM0.8881.124-0.236
YOY0.7011.090-0.389
5Y0.7261.100-0.374
10Y0.7021.060-0.358

1.3. Liquidity of Coloplast A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Coloplast is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.53 means the company has kr0.53 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Coloplast A/S:

  • The MRQ is 0.532. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.778. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.532TTM0.778-0.246
TTM0.778YOY0.855-0.076
TTM0.7785Y0.964-0.185
5Y0.96410Y1.103-0.140
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5322.323-1.791
TTM0.7782.387-1.609
YOY0.8552.582-1.727
5Y0.9642.631-1.667
10Y1.1032.627-1.524
1.3.2. Quick Ratio

Measures if Coloplast is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.23 means the company can pay off kr0.23 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Coloplast A/S:

  • The MRQ is 0.232. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.373. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.373-0.140
TTM0.373YOY0.526-0.153
TTM0.3735Y0.610-0.238
5Y0.61010Y0.539+0.071
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2321.113-0.881
TTM0.3731.148-0.775
YOY0.5261.296-0.770
5Y0.6101.427-0.817
10Y0.5391.527-0.988

1.4. Solvency of Coloplast A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Coloplast assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Coloplast to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.69 means that Coloplast assets are financed with 68.9% credit (debt) and the remaining percentage (100% - 68.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Coloplast A/S:

  • The MRQ is 0.689. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.736. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.689TTM0.736-0.048
TTM0.736YOY0.795-0.059
TTM0.7365Y0.624+0.112
5Y0.62410Y0.574+0.050
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6890.354+0.335
TTM0.7360.357+0.379
YOY0.7950.358+0.437
5Y0.6240.362+0.262
10Y0.5740.373+0.201
1.4.2. Debt to Equity Ratio

Measures if Coloplast is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 221.3% means that company has kr2.21 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Coloplast A/S:

  • The MRQ is 2.213. The company is just not able to pay all its debts with equity.
  • The TTM is 3.105. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.213TTM3.105-0.893
TTM3.105YOY3.963-0.858
TTM3.1055Y2.105+1.001
5Y2.10510Y1.639+0.466
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2130.541+1.672
TTM3.1050.557+2.548
YOY3.9630.551+3.412
5Y2.1050.621+1.484
10Y1.6390.669+0.970

2. Market Valuation of Coloplast A/S

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Coloplast generates.

  • Above 15 is considered overpriced but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 35.80 means the investor is paying kr35.80 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Coloplast A/S:

  • The EOD is 42.442. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.801. Based on the earnings, the company is overpriced. -1
  • The TTM is 36.774. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD42.442MRQ35.801+6.641
MRQ35.801TTM36.774-0.972
TTM36.774YOY40.207-3.433
TTM36.7745Y42.910-6.137
5Y42.91010Y5.530+37.381
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD42.44214.512+27.930
MRQ35.80117.788+18.013
TTM36.77418.314+18.460
YOY40.20722.147+18.060
5Y42.91020.547+22.363
10Y5.53024.933-19.403
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Coloplast A/S:

  • The EOD is 34.021. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 28.698. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 57.184. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD34.021MRQ28.698+5.323
MRQ28.698TTM57.184-28.486
TTM57.184YOY-653.018+710.202
TTM57.1845Y-221.022+278.206
5Y-221.02210Y-67.337-153.685
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD34.0219.665+24.356
MRQ28.6989.336+19.362
TTM57.1840.922+56.262
YOY-653.0184.052-657.070
5Y-221.0227.995-229.017
10Y-67.3370.503-67.840
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Coloplast is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 11.48 means the investor is paying kr11.48 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Coloplast A/S:

  • The EOD is 13.604. Based on the equity, the company is expensive. -2
  • The MRQ is 11.475. Based on the equity, the company is expensive. -2
  • The TTM is 19.095. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD13.604MRQ11.475+2.129
MRQ11.475TTM19.095-7.619
TTM19.095YOY25.689-6.594
TTM19.0955Y27.177-8.083
5Y27.17710Y24.245+2.932
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD13.6042.519+11.085
MRQ11.4752.759+8.716
TTM19.0952.827+16.268
YOY25.6893.284+22.405
5Y27.1773.524+23.653
10Y24.2454.198+20.047
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Coloplast A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.7269.868-199%-0.575-94%2.143-554%0.973-1099%
Book Value Per Share--67.27551.976+29%33.781+99%35.708+88%30.275+122%
Current Ratio--0.5320.778-32%0.855-38%0.964-45%1.103-52%
Debt To Asset Ratio--0.6890.736-6%0.795-13%0.624+10%0.574+20%
Debt To Equity Ratio--2.2133.105-29%3.963-44%2.105+5%1.639+35%
Dividend Per Share--15.9905.246+205%9.987+60%7.590+111%6.426+149%
Eps--5.3915.570-3%5.437-1%5.279+2%4.319+25%
Free Cash Flow Per Share--6.7254.848+39%3.816+76%4.353+54%3.840+75%
Free Cash Flow To Equity Per Share--6.7253.344+101%12.505-46%3.216+109%1.732+288%
Gross Profit Margin--1.0000.226+343%-0.559+156%-0.219+122%1.0000%
Intrinsic Value_10Y_max--539.399--------
Intrinsic Value_10Y_min--177.794--------
Intrinsic Value_1Y_max--23.450--------
Intrinsic Value_1Y_min--15.879--------
Intrinsic Value_3Y_max--93.780--------
Intrinsic Value_3Y_min--49.670--------
Intrinsic Value_5Y_max--192.227--------
Intrinsic Value_5Y_min--85.351--------
Market Cap189286232678.400+8%173564764900.000178636561324.000-3%181925279432.300-5%191518489778.260-9%151125402829.883+15%
Net Profit Margin--0.1830.195-6%0.197-7%0.217-15%0.203-10%
Operating Margin---0.139-100%0.279-100%0.274-100%0.299-100%
Operating Ratio--1.0420.888+17%0.701+49%0.726+44%0.702+49%
Pb Ratio13.604+16%11.47519.095-40%25.689-55%27.177-58%24.245-53%
Pe Ratio42.442+16%35.80136.774-3%40.207-11%42.910-17%5.530+547%
Price Per Share915.200+16%772.000818.650-6%855.175-10%895.335-14%708.320+9%
Price To Free Cash Flow Ratio34.021+16%28.69857.184-50%-653.018+2375%-221.022+870%-67.337+335%
Price To Total Gains Ratio146.104+16%123.243166.599-26%131.409-6%151.640-19%117.293+5%
Quick Ratio--0.2320.373-38%0.526-56%0.610-62%0.539-57%
Return On Assets--0.0250.030-16%0.033-24%0.059-58%0.061-59%
Return On Equity--0.0800.128-37%0.163-51%0.159-49%0.147-46%
Total Gains Per Share--6.26415.114-59%9.412-33%9.733-36%7.400-15%
Usd Book Value--2159850000.0001640343600.000+32%1026196500.000+110%1097725020.000+97%925579620.000+133%
Usd Book Value Change Per Share---1.3891.409-199%-0.082-94%0.306-554%0.139-1099%
Usd Book Value Per Share--9.6077.422+29%4.824+99%5.099+88%4.323+122%
Usd Dividend Per Share--2.2830.749+205%1.426+60%1.084+111%0.918+149%
Usd Eps--0.7700.795-3%0.776-1%0.754+2%0.617+25%
Usd Free Cash Flow--215913600.000152974500.000+41%115882200.000+86%133468020.000+62%117163830.000+84%
Usd Free Cash Flow Per Share--0.9600.692+39%0.545+76%0.622+54%0.548+75%
Usd Free Cash Flow To Equity Per Share--0.9600.478+101%1.786-46%0.459+109%0.247+288%
Usd Market Cap27030074026.476+8%24785048427.72025509300957.067-3%25978929902.932-5%27348840340.336-9%21580707524.107+15%
Usd Price Per Share130.691+16%110.242116.903-6%122.119-10%127.854-14%101.148+9%
Usd Profit--173073600.000173787600.0000%165148200.000+5%161399700.000+7%131697300.000+31%
Usd Revenue--943336800.000892535700.000+6%839485500.000+12%751649220.000+26%640907820.000+47%
Usd Total Gains Per Share--0.8952.158-59%1.344-33%1.390-36%1.057-15%
 EOD+4 -4MRQTTM+18 -18YOY+16 -205Y+18 -1810Y+19 -17

3.2. Fundamental Score

Let's check the fundamental score of Coloplast A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1542.442
Price to Book Ratio (EOD)Between0-113.604
Net Profit Margin (MRQ)Greater than00.183
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.232
Current Ratio (MRQ)Greater than10.532
Debt to Asset Ratio (MRQ)Less than10.689
Debt to Equity Ratio (MRQ)Less than12.213
Return on Equity (MRQ)Greater than0.150.080
Return on Assets (MRQ)Greater than0.050.025
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.179
Ma 20Greater thanMa 50924.460
Ma 50Greater thanMa 100907.824
Ma 100Greater thanMa 200842.126
OpenGreater thanClose910.800
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets48,591,000
Total Liabilities33,466,000
Total Stockholder Equity15,125,000
 As reported
Total Liabilities 33,466,000
Total Stockholder Equity+ 15,125,000
Total Assets = 48,591,000

Assets

Total Assets48,591,000
Total Current Assets10,069,000
Long-term Assets38,522,000
Total Current Assets
Cash And Cash Equivalents 916,000
Net Receivables 4,392,000
Inventory 3,519,000
Total Current Assets  (as reported)10,069,000
Total Current Assets  (calculated)8,827,000
+/- 1,242,000
Long-term Assets
Property Plant Equipment 6,073,000
Long-term Assets  (as reported)38,522,000
Long-term Assets  (calculated)6,073,000
+/- 32,449,000

Liabilities & Shareholders' Equity

Total Current Liabilities18,918,000
Long-term Liabilities14,548,000
Total Stockholder Equity15,125,000
Total Current Liabilities
Short Long Term Debt 9,192,000
Accounts payable 1,162,000
Total Current Liabilities  (as reported)18,918,000
Total Current Liabilities  (calculated)10,354,000
+/- 8,564,000
Long-term Liabilities
Long term Debt 11,553,000
Capital Lease Obligations Min Short Term Debt885,000
Long-term Liabilities  (as reported)14,548,000
Long-term Liabilities  (calculated)12,438,000
+/- 2,110,000
Total Stockholder Equity
Retained Earnings 15,935,000
Total Stockholder Equity (as reported)15,125,000
Total Stockholder Equity (calculated)15,935,000
+/- 810,000
Other
Capital Stock228,000
Common Stock Shares Outstanding 224,825
Net Debt 19,829,000
Net Invested Capital 35,870,000
Net Working Capital -8,849,000
Property Plant and Equipment Gross 6,073,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
0
0
0
7,963,000
7,545,000
7,620,000
7,912,000
7,771,000
8,116,000
8,228,000
8,493,000
9,218,000
8,916,000
9,300,000
9,980,000
10,176,000
9,773,000
10,066,000
8,637,000
9,364,000
8,403,000
9,278,000
9,121,000
10,379,000
9,663,000
10,620,000
9,945,000
10,817,000
10,810,000
10,602,000
11,280,000
11,007,000
12,883,000
12,511,000
12,247,000
12,050,000
12,193,000
12,751,000
12,667,000
11,769,000
12,113,000
12,292,000
12,551,000
12,732,000
13,223,000
13,528,000
13,315,000
13,499,000
14,926,000
15,249,000
15,458,000
15,841,000
16,188,000
35,170,000
35,185,000
34,956,000
35,221,000
35,302,000
35,087,000
48,159,000
48,591,000
48,591,00048,159,00035,087,00035,302,00035,221,00034,956,00035,185,00035,170,00016,188,00015,841,00015,458,00015,249,00014,926,00013,499,00013,315,00013,528,00013,223,00012,732,00012,551,00012,292,00012,113,00011,769,00012,667,00012,751,00012,193,00012,050,00012,247,00012,511,00012,883,00011,007,00011,280,00010,602,00010,810,00010,817,0009,945,00010,620,0009,663,00010,379,0009,121,0009,278,0008,403,0009,364,0008,637,00010,066,0009,773,00010,176,0009,980,0009,300,0008,916,0009,218,0008,493,0008,228,0008,116,0007,771,0007,912,0007,620,0007,545,0007,963,000000
   > Total Current Assets 
0
0
0
3,369,000
2,997,000
3,007,000
3,188,000
3,353,000
3,491,000
3,775,000
4,145,000
4,965,000
4,664,000
5,128,000
5,720,000
5,969,000
5,654,000
5,975,000
4,551,000
5,366,000
4,426,000
5,095,000
4,972,000
6,047,000
5,251,000
5,884,000
5,338,000
5,765,000
5,733,000
6,009,000
6,646,000
6,164,000
6,915,000
6,608,000
6,518,000
6,194,000
6,322,000
6,641,000
6,494,000
5,590,000
5,929,000
6,097,000
6,415,000
6,359,000
6,361,000
6,709,000
6,490,000
6,489,000
6,640,000
6,707,000
6,827,000
6,994,000
7,284,000
8,169,000
8,703,000
8,772,000
9,279,000
9,323,000
9,673,000
9,937,000
10,069,000
10,069,0009,937,0009,673,0009,323,0009,279,0008,772,0008,703,0008,169,0007,284,0006,994,0006,827,0006,707,0006,640,0006,489,0006,490,0006,709,0006,361,0006,359,0006,415,0006,097,0005,929,0005,590,0006,494,0006,641,0006,322,0006,194,0006,518,0006,608,0006,915,0006,164,0006,646,0006,009,0005,733,0005,765,0005,338,0005,884,0005,251,0006,047,0004,972,0005,095,0004,426,0005,366,0004,551,0005,975,0005,654,0005,969,0005,720,0005,128,0004,664,0004,965,0004,145,0003,775,0003,491,0003,353,0003,188,0003,007,0002,997,0003,369,000000
       Cash And Cash Equivalents 
0
0
0
629,000
278,000
237,000
335,000
475,000
350,000
381,000
454,000
1,318,000
848,000
1,496,000
1,914,000
1,973,000
988,000
1,417,000
617,000
1,504,000
462,000
454,000
404,000
971,000
428,000
656,000
644,000
881,000
412,000
402,000
424,000
546,000
545,000
442,000
314,000
314,000
505,000
608,000
450,000
297,000
432,000
312,000
444,000
356,000
516,000
498,000
411,000
323,000
435,000
418,000
447,000
448,000
642,000
517,000
634,000
414,000
671,000
628,000
855,000
911,000
916,000
916,000911,000855,000628,000671,000414,000634,000517,000642,000448,000447,000418,000435,000323,000411,000498,000516,000356,000444,000312,000432,000297,000450,000608,000505,000314,000314,000442,000545,000546,000424,000402,000412,000881,000644,000656,000428,000971,000404,000454,000462,0001,504,000617,0001,417,000988,0001,973,0001,914,0001,496,000848,0001,318,000454,000381,000350,000475,000335,000237,000278,000629,000000
       Short-term Investments 
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
180,000
471,000
568,000
659,000
456,000
608,000
645,000
1,337,000
1,149,000
335,000
367,000
475,000
632,000
401,000
619,000
200,000
216,000
210,000
519,000
201,000
200,000
200,000
489,000
379,000
334,000
313,000
315,000
316,000
311,000
311,000
310,000
305,000
308,000
311,000
313,000
304,000
302,000
262,000
262,000
257,000
257,000
228,000
226,000
222,000
220,000
220,000
219,000
210,000
16,000
0
0
0
00016,000210,000219,000220,000220,000222,000226,000228,000257,000257,000262,000262,000302,000304,000313,000311,000308,000305,000310,000311,000311,000316,000315,000313,000334,000379,000489,000200,000200,000201,000519,000210,000216,000200,000619,000401,000632,000475,000367,000335,0001,149,0001,337,000645,000608,000456,000659,000568,000471,000180,0001,0001,0001,0001,0001,0001,000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,970,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,124,000
3,222,000
3,190,000
3,071,000
3,174,000
3,201,000
3,085,000
3,120,000
3,113,000
3,227,000
3,153,000
3,399,000
3,794,000
3,526,000
3,514,000
3,545,000
3,563,000
3,609,000
3,720,000
3,742,000
4,321,000
4,613,000
4,659,000
3,953,000
3,988,000
4,072,000
4,315,000
4,392,000
4,392,0004,315,0004,072,0003,988,0003,953,0004,659,0004,613,0004,321,0003,742,0003,720,0003,609,0003,563,0003,545,0003,514,0003,526,0003,794,0003,399,0003,153,0003,227,0003,113,0003,120,0003,085,0003,201,0003,174,0003,071,0003,190,0003,222,0003,124,0000000000000000000000000001,970,00000000000
       Other Current Assets 
0
0
0
1,753,000
1,803,000
1,788,000
1,890,000
1,918,000
186,000
2,182,000
2,220,000
2,133,000
2,200,000
2,231,000
2,236,000
2,343,000
2,305,000
2,349,000
2,512,000
2,426,000
2,407,000
2,846,000
2,949,000
3,135,000
3,239,000
3,545,000
3,000,000
2,892,000
3,615,000
3,952,000
4,520,000
3,611,000
4,365,000
4,090,000
4,149,000
3,873,000
3,815,000
4,043,000
4,054,000
3,258,000
3,374,000
3,608,000
3,746,000
3,757,000
3,624,000
3,994,000
3,701,000
3,677,000
3,717,000
3,743,000
3,774,000
3,892,000
3,923,000
4,562,000
4,827,000
4,952,000
5,001,000
0
0
0
0
00005,001,0004,952,0004,827,0004,562,0003,923,0003,892,0003,774,0003,743,0003,717,0003,677,0003,701,0003,994,0003,624,0003,757,0003,746,0003,608,0003,374,0003,258,0004,054,0004,043,0003,815,0003,873,0004,149,0004,090,0004,365,0003,611,0004,520,0003,952,0003,615,0002,892,0003,000,0003,545,0003,239,0003,135,0002,949,0002,846,0002,407,0002,426,0002,512,0002,349,0002,305,0002,343,0002,236,0002,231,0002,200,0002,133,0002,220,0002,182,000186,0001,918,0001,890,0001,788,0001,803,0001,753,000000
   > Long-term Assets 
0
0
0
4,594,000
4,548,000
4,613,000
4,724,000
4,418,000
4,625,000
4,453,000
4,348,000
4,253,000
4,252,000
4,172,000
4,260,000
4,207,000
4,119,000
4,091,000
4,086,000
3,998,000
3,977,000
4,183,000
4,149,000
4,332,000
4,412,000
4,736,000
4,607,000
5,052,000
5,077,000
4,593,000
4,634,000
4,843,000
5,968,000
5,903,000
5,729,000
5,856,000
5,871,000
6,110,000
6,173,000
6,179,000
6,184,000
6,195,000
6,136,000
6,373,000
6,862,000
6,819,000
6,825,000
7,010,000
8,286,000
8,542,000
8,631,000
8,847,000
8,904,000
27,001,000
26,482,000
26,184,000
25,942,000
25,979,000
25,414,000
38,222,000
38,522,000
38,522,00038,222,00025,414,00025,979,00025,942,00026,184,00026,482,00027,001,0008,904,0008,847,0008,631,0008,542,0008,286,0007,010,0006,825,0006,819,0006,862,0006,373,0006,136,0006,195,0006,184,0006,179,0006,173,0006,110,0005,871,0005,856,0005,729,0005,903,0005,968,0004,843,0004,634,0004,593,0005,077,0005,052,0004,607,0004,736,0004,412,0004,332,0004,149,0004,183,0003,977,0003,998,0004,086,0004,091,0004,119,0004,207,0004,260,0004,172,0004,252,0004,253,0004,348,0004,453,0004,625,0004,418,0004,724,0004,613,0004,548,0004,594,000000
       Property Plant Equipment 
0
0
0
2,635,000
2,596,000
2,601,000
2,596,000
5,827,000
2,435,000
2,392,000
2,349,000
2,266,000
2,094,000
2,240,000
2,092,000
2,286,000
2,257,000
2,218,000
2,267,000
2,286,000
2,317,000
2,309,000
2,368,000
2,462,000
2,516,000
2,712,000
2,669,000
2,705,000
2,727,000
2,717,000
2,762,000
2,925,000
2,919,000
2,928,000
2,937,000
3,072,000
3,134,000
3,125,000
3,151,000
3,169,000
3,175,000
3,179,000
3,146,000
3,249,000
3,786,000
3,760,000
3,798,000
3,926,000
4,045,000
4,168,000
4,232,000
4,386,000
4,421,000
4,884,000
4,920,000
5,151,000
5,396,000
5,617,000
5,793,000
5,979,000
6,073,000
6,073,0005,979,0005,793,0005,617,0005,396,0005,151,0004,920,0004,884,0004,421,0004,386,0004,232,0004,168,0004,045,0003,926,0003,798,0003,760,0003,786,0003,249,0003,146,0003,179,0003,175,0003,169,0003,151,0003,125,0003,134,0003,072,0002,937,0002,928,0002,919,0002,925,0002,762,0002,717,0002,727,0002,705,0002,669,0002,712,0002,516,0002,462,0002,368,0002,309,0002,317,0002,286,0002,267,0002,218,0002,257,0002,286,0002,092,0002,240,0002,094,0002,266,0002,349,0002,392,0002,435,0005,827,0002,596,0002,601,0002,596,0002,635,000000
       Goodwill 
0
0
0
629,000
639,000
674,000
732,000
670,000
785,000
746,000
736,000
737,000
764,000
743,000
783,000
0
750,000
768,000
757,000
735,000
723,000
726,000
730,000
772,000
799,000
877,000
847,000
842,000
862,000
834,000
847,000
844,000
1,800,000
1,772,000
1,665,000
1,724,000
0
0
0
1,984,000
0
0
0
2,030,000
0
0
0
1,976,000
0
0
0
2,028,000
0
10,130,000
0
11,808,000
0
0
0
19,974,000
0
019,974,00000011,808,000010,130,00002,028,0000001,976,0000002,030,0000001,984,0000001,724,0001,665,0001,772,0001,800,000844,000847,000834,000862,000842,000847,000877,000799,000772,000730,000726,000723,000735,000757,000768,000750,0000783,000743,000764,000737,000736,000746,000785,000670,000732,000674,000639,000629,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,000
12,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
5,000
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,0005,00010,00010,00010,00010,00010,00010,00010,00010,00012,00012,000000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,179,000
1,162,000
1,184,000
1,220,000
123,000
1,201,000
1,114,000
1,064,000
1,065,000
1,193,000
989,000
1,179,000
0
883,000
867,000
827,000
781,000
742,000
713,000
690,000
709,000
705,000
740,000
697,000
669,000
652,000
604,000
583,000
553,000
732,000
686,000
619,000
571,000
2,248,000
2,495,000
2,533,000
534,000
2,516,000
2,517,000
2,486,000
472,000
2,459,000
0
0
388,000
0
0
0
1,623,000
0
11,069,000
0
8,469,000
0
0
0
11,281,000
0
011,281,0000008,469,000011,069,00001,623,000000388,000002,459,000472,0002,486,0002,517,0002,516,000534,0002,533,0002,495,0002,248,000571,000619,000686,000732,000553,000583,000604,000652,000669,000697,000740,000705,000709,000690,000713,000742,000781,000827,000867,000883,00001,179,000989,0001,193,0001,065,0001,064,0001,114,0001,201,000123,0001,220,0001,184,0001,162,0001,179,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900,000
893,000
884,000
479,000
480,000
479,000
800,000
483,000
489,000
494,000
1,078,000
612,000
599,000
604,000
1,533,000
692,000
735,000
740,000
1,655,000
765,000
877,000
876,000
1,891,000
693,000
0
0
0
0
0000693,0001,891,000876,000877,000765,0001,655,000740,000735,000692,0001,533,000604,000599,000612,0001,078,000494,000489,000483,000800,000479,000480,000479,000884,000893,000900,000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,113,000
4,666,000
4,540,000
4,790,000
4,319,000
4,594,000
4,454,000
4,506,000
4,740,000
4,476,000
4,332,000
4,582,000
4,134,000
3,852,000
3,716,000
2,482,000
2,595,000
2,313,000
3,431,000
3,698,000
4,096,000
4,268,000
4,147,000
4,152,000
6,111,000
6,784,000
5,679,000
6,781,000
5,939,000
8,669,000
7,447,000
7,289,000
6,098,000
7,482,000
7,375,000
7,465,000
5,351,000
6,921,000
6,119,000
6,612,000
5,819,000
7,772,000
6,942,000
6,953,000
6,093,000
9,156,000
8,313,000
8,531,000
7,673,000
9,769,000
27,897,000
27,910,000
26,664,000
29,316,000
28,268,000
28,597,000
30,860,000
33,466,000
33,466,00030,860,00028,597,00028,268,00029,316,00026,664,00027,910,00027,897,0009,769,0007,673,0008,531,0008,313,0009,156,0006,093,0006,953,0006,942,0007,772,0005,819,0006,612,0006,119,0006,921,0005,351,0007,465,0007,375,0007,482,0006,098,0007,289,0007,447,0008,669,0005,939,0006,781,0005,679,0006,784,0006,111,0004,152,0004,147,0004,268,0004,096,0003,698,0003,431,0002,313,0002,595,0002,482,0003,716,0003,852,0004,134,0004,582,0004,332,0004,476,0004,740,0004,506,0004,454,0004,594,0004,319,0004,790,0004,540,0004,666,0005,113,000000
   > Total Current Liabilities 
0
0
0
1,987,000
1,804,000
1,898,000
2,239,000
2,058,000
1,801,000
1,670,000
1,714,000
2,087,000
1,904,000
1,751,000
3,415,000
3,708,000
3,406,000
3,263,000
2,061,000
2,266,000
1,980,000
2,041,000
2,935,000
3,529,000
3,815,000
3,814,000
3,845,000
4,578,000
5,546,000
4,781,000
6,317,000
5,309,000
8,220,000
6,982,000
6,836,000
5,425,000
6,826,000
6,701,000
6,800,000
4,708,000
6,281,000
5,453,000
5,955,000
4,942,000
6,648,000
5,894,000
5,923,000
4,979,000
7,782,000
6,822,000
7,116,000
6,314,000
8,477,000
24,811,000
8,635,000
7,336,000
10,482,000
9,433,000
9,838,000
16,311,000
18,918,000
18,918,00016,311,0009,838,0009,433,00010,482,0007,336,0008,635,00024,811,0008,477,0006,314,0007,116,0006,822,0007,782,0004,979,0005,923,0005,894,0006,648,0004,942,0005,955,0005,453,0006,281,0004,708,0006,800,0006,701,0006,826,0005,425,0006,836,0006,982,0008,220,0005,309,0006,317,0004,781,0005,546,0004,578,0003,845,0003,814,0003,815,0003,529,0002,935,0002,041,0001,980,0002,266,0002,061,0003,263,0003,406,0003,708,0003,415,0001,751,0001,904,0002,087,0001,714,0001,670,0001,801,0002,058,0002,239,0001,898,0001,804,0001,987,000000
       Short-term Debt 
0
0
0
233,000
264,000
335,000
345,000
172,000
207,000
174,000
113,000
98,000
156,000
0
1,343,000
1,296,000
1,335,000
1,311,000
146,000
111,000
129,000
130,000
154,000
92,000
367,000
467,000
779,000
100,000
391,000
25,000
923,000
222,000
2,880,000
2,662,000
2,547,000
1,358,000
2,895,000
3,183,000
2,975,000
1,270,000
3,045,000
2,592,000
2,848,000
1,074,000
3,156,000
2,767,000
2,671,000
1,317,000
4,194,000
3,670,000
3,848,000
2,337,000
4,606,000
20,601,000
3,719,000
1,853,000
5,168,000
4,606,000
5,052,000
0
0
005,052,0004,606,0005,168,0001,853,0003,719,00020,601,0004,606,0002,337,0003,848,0003,670,0004,194,0001,317,0002,671,0002,767,0003,156,0001,074,0002,848,0002,592,0003,045,0001,270,0002,975,0003,183,0002,895,0001,358,0002,547,0002,662,0002,880,000222,000923,00025,000391,000100,000779,000467,000367,00092,000154,000130,000129,000111,000146,0001,311,0001,335,0001,296,0001,343,0000156,00098,000113,000174,000207,000172,000345,000335,000264,000233,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,662,000
2,547,000
1,358,000
2,895,000
3,183,000
2,975,000
1,262,000
3,039,000
2,584,000
2,840,000
1,066,000
2,989,000
2,616,000
2,515,000
1,111,000
4,021,000
3,501,000
3,683,000
2,160,000
4,435,000
20,392,000
3,514,000
1,644,000
4,965,000
4,392,000
4,834,000
7,115,000
9,192,000
9,192,0007,115,0004,834,0004,392,0004,965,0001,644,0003,514,00020,392,0004,435,0002,160,0003,683,0003,501,0004,021,0001,111,0002,515,0002,616,0002,989,0001,066,0002,840,0002,584,0003,039,0001,262,0002,975,0003,183,0002,895,0001,358,0002,547,0002,662,000000000000000000000000000000000000
       Accounts payable 
0
0
0
428,000
366,000
344,000
414,000
455,000
1,378,000
428,000
368,000
420,000
399,000
379,000
368,000
478,000
352,000
419,000
433,000
418,000
367,000
430,000
454,000
566,000
396,000
503,000
448,000
591,000
441,000
441,000
525,000
697,000
512,000
566,000
527,000
675,000
550,000
615,000
659,000
751,000
636,000
664,000
673,000
859,000
679,000
664,000
623,000
814,000
563,000
572,000
531,000
1,036,000
597,000
755,000
826,000
1,242,000
964,000
1,136,000
1,070,000
1,294,000
1,162,000
1,162,0001,294,0001,070,0001,136,000964,0001,242,000826,000755,000597,0001,036,000531,000572,000563,000814,000623,000664,000679,000859,000673,000664,000636,000751,000659,000615,000550,000675,000527,000566,000512,000697,000525,000441,000441,000591,000448,000503,000396,000566,000454,000430,000367,000418,000433,000419,000352,000478,000368,000379,000399,000420,000368,000428,0001,378,000455,000414,000344,000366,000428,000000
       Other Current Liabilities 
0
0
0
1,084,000
1,005,000
1,008,000
1,212,000
941,000
34,000
847,000
877,000
1,053,000
1,171,000
1,372,000
1,192,000
1,263,000
1,361,000
1,137,000
857,000
973,000
1,160,000
1,292,000
1,998,000
2,350,000
2,722,000
2,613,000
2,485,000
3,822,000
4,393,000
4,211,000
4,534,000
15,000
11,000
8,000
4,000
11,000
9,000
6,000
3,000
11,000
9,000
6,000
4,000
11,000
9,000
5,000
3,000
9,000
7,000
4,000
2,000
8,000
6,000
3,455,000
4,090,000
4,241,000
4,350,000
3,691,000
1,000
1,000
0
01,0001,0003,691,0004,350,0004,241,0004,090,0003,455,0006,0008,0002,0004,0007,0009,0003,0005,0009,00011,0004,0006,0009,00011,0003,0006,0009,00011,0004,0008,00011,00015,0004,534,0004,211,0004,393,0003,822,0002,485,0002,613,0002,722,0002,350,0001,998,0001,292,0001,160,000973,000857,0001,137,0001,361,0001,263,0001,192,0001,372,0001,171,0001,053,000877,000847,00034,000941,0001,212,0001,008,0001,005,0001,084,000000
   > Long-term Liabilities 
0
0
0
3,126,000
2,862,000
2,642,000
2,551,000
2,261,000
2,793,000
2,784,000
2,792,000
2,653,000
2,572,000
2,581,000
1,167,000
426,000
446,000
453,000
421,000
329,000
333,000
1,390,000
763,000
567,000
453,000
333,000
307,000
1,533,000
1,238,000
898,000
464,000
630,000
449,000
465,000
453,000
673,000
656,000
674,000
665,000
643,000
640,000
666,000
657,000
877,000
1,124,000
1,048,000
1,030,000
1,114,000
1,374,000
1,491,000
1,415,000
1,359,000
1,292,000
3,086,000
19,275,000
19,328,000
18,834,000
18,835,000
18,759,000
14,549,000
14,548,000
14,548,00014,549,00018,759,00018,835,00018,834,00019,328,00019,275,0003,086,0001,292,0001,359,0001,415,0001,491,0001,374,0001,114,0001,030,0001,048,0001,124,000877,000657,000666,000640,000643,000665,000674,000656,000673,000453,000465,000449,000630,000464,000898,0001,238,0001,533,000307,000333,000453,000567,000763,0001,390,000333,000329,000421,000453,000446,000426,0001,167,0002,581,0002,572,0002,653,0002,792,0002,784,0002,793,0002,261,0002,551,0002,642,0002,862,0003,126,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
465,000
453,000
575,000
656,000
573,000
568,000
552,000
548,000
578,000
573,000
743,000
706,000
646,000
650,000
684,000
903,000
1,036,000
982,000
910,000
862,000
2,603,000
2,399,000
2,473,000
1,809,000
0
0
0
0
00001,809,0002,473,0002,399,0002,603,000862,000910,000982,0001,036,000903,000684,000650,000646,000706,000743,000573,000578,000548,000552,000568,000573,000656,000575,000453,000465,000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,850,000
2,879,000
3,080,000
3,122,000
3,452,000
3,522,000
3,774,000
3,987,000
4,478,000
4,440,000
4,968,000
5,398,000
6,042,000
5,921,000
6,350,000
6,155,000
6,769,000
6,090,000
5,847,000
5,423,000
6,283,000
5,395,000
6,473,000
5,793,000
4,706,000
4,026,000
4,923,000
4,499,000
5,068,000
4,214,000
5,064,000
4,958,000
5,952,000
4,711,000
5,376,000
5,202,000
6,418,000
5,192,000
6,173,000
5,939,000
6,913,000
5,451,000
6,586,000
6,362,000
7,406,000
5,770,000
6,936,000
6,927,000
8,168,000
6,419,000
7,273,000
7,275,000
8,292,000
5,905,000
7,034,000
6,490,000
17,299,000
15,125,000
15,125,00017,299,0006,490,0007,034,0005,905,0008,292,0007,275,0007,273,0006,419,0008,168,0006,927,0006,936,0005,770,0007,406,0006,362,0006,586,0005,451,0006,913,0005,939,0006,173,0005,192,0006,418,0005,202,0005,376,0004,711,0005,952,0004,958,0005,064,0004,214,0005,068,0004,499,0004,923,0004,026,0004,706,0005,793,0006,473,0005,395,0006,283,0005,423,0005,847,0006,090,0006,769,0006,155,0006,350,0005,921,0006,042,0005,398,0004,968,0004,440,0004,478,0003,987,0003,774,0003,522,0003,452,0003,122,0003,080,0002,879,0002,850,000000
   Common Stock
0
0
0
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
0
0
00216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
251,000
-44,000
-60,000
-128,000
-21,000
-44,000
34,000
40,000
-32,000
-99,000
-63,000
-72,000
-40,000
34,000
660,000
77,000
1,419,000
-43,000
705,000
-183,000
1,358,000
-205,000
815,000
-200,000
1,630,000
-5,000
959,000
-78,000
1,868,000
-84,000
886,000
-7,000
2,197,000
-45,000
950,000
-167,000
2,139,000
-135,000
897,000
-134,000
2,321,000
-246,000
771,000
-278,000
2,450,000
-322,000
640,000
-400,000
2,546,000
-465,000
875,000
-370,000
2,690,000
-762,000
246,000
-1,603,000
0
0
00-1,603,000246,000-762,0002,690,000-370,000875,000-465,0002,546,000-400,000640,000-322,0002,450,000-278,000771,000-246,0002,321,000-134,000897,000-135,0002,139,000-167,000950,000-45,0002,197,000-7,000886,000-84,0001,868,000-78,000959,000-5,0001,630,000-200,000815,000-205,0001,358,000-183,000705,000-43,0001,419,00077,000660,00034,000-40,000-72,000-63,000-99,000-32,00040,00034,000-44,000-21,000-128,000-60,000-44,000251,000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue24,500,000
Cost of Revenue-8,172,000
Gross Profit16,328,00016,328,000
 
Operating Income (+$)
Gross Profit16,328,000
Operating Expense-17,655,000
Operating Income6,845,000-1,327,000
 
Operating Expense (+$)
Research Development872,000
Selling General Administrative8,633,000
Selling And Marketing Expenses0
Operating Expense17,655,0009,505,000
 
Net Interest Income (+$)
Interest Income111,000
Interest Expense-638,000
Other Finance Cost-77,000
Net Interest Income-604,000
 
Pretax Income (+$)
Operating Income6,845,000
Net Interest Income-604,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)6,025,0006,845,000
EBIT - interestExpense = -638,000
4,783,000
5,421,000
Interest Expense638,000
Earnings Before Interest and Taxes (EBIT)06,663,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax6,025,000
Tax Provision-1,242,000
Net Income From Continuing Ops4,783,0004,783,000
Net Income4,783,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0604,000
 

Technical Analysis of Coloplast
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Coloplast. The general trend of Coloplast is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Coloplast's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Coloplast A/S.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 913.40 < 977.60.

The bearish price targets are: 902.40 > 857.75 > 837.18.

Tweet this
Coloplast A/S Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Coloplast A/S. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Coloplast A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Coloplast A/S. The current macd is 0.98481043.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Coloplast price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Coloplast. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Coloplast price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Coloplast A/S Daily Moving Average Convergence/Divergence (MACD) ChartColoplast A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Coloplast A/S. The current adx is 19.88.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Coloplast shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Coloplast A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Coloplast A/S. The current sar is 947.20.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Coloplast A/S Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Coloplast A/S. The current rsi is 48.18. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Coloplast A/S Daily Relative Strength Index (RSI) ChartColoplast A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Coloplast A/S. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Coloplast price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Coloplast A/S Daily Stochastic Oscillator ChartColoplast A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Coloplast A/S. The current cci is -117.77685836.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Coloplast A/S Daily Commodity Channel Index (CCI) ChartColoplast A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Coloplast A/S. The current cmo is -10.86440014.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Coloplast A/S Daily Chande Momentum Oscillator (CMO) ChartColoplast A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Coloplast A/S. The current willr is -78.43137255.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Coloplast is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Coloplast A/S Daily Williams %R ChartColoplast A/S Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Coloplast A/S.

Coloplast A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Coloplast A/S. The current atr is 16.61.

Coloplast A/S Daily Average True Range (ATR) ChartColoplast A/S Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Coloplast A/S. The current obv is -2,721,236.

Coloplast A/S Daily On-Balance Volume (OBV) ChartColoplast A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Coloplast A/S. The current mfi is 43.18.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Coloplast A/S Daily Money Flow Index (MFI) ChartColoplast A/S Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Coloplast A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Coloplast A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.179
Ma 20Greater thanMa 50924.460
Ma 50Greater thanMa 100907.824
Ma 100Greater thanMa 200842.126
OpenGreater thanClose910.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Coloplast with someone you think should read this too:
  • Are you bullish or bearish on Coloplast? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Coloplast? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Coloplast A/S

I send you an email if I find something interesting about Coloplast A/S.


Comments

How you think about this?

Leave a comment

Stay informed about Coloplast A/S.

Receive notifications about Coloplast A/S in your mailbox!